Gain-of-Function Research: Summary of the Second Symposium, March 10-11, 2016 (2016)
Chapter: Appendix C: Symposium Agenda
Appendix C
Symposium Agenda
National Academy of Sciences Building
2101 Constitution Avenue NW
Washington, DC 20418
March 10-11, 2016
| Thursday, March 10: Overview and Context | |
| 8:00 am | Registration (coffee and tea will be served) |
| 8:45 |
Welcome and Opening Remarks
Moderator: Harvey Fineberg, Symposium Planning Committee Chair |
|
Ralph J. Cicerone, President, National Academy of Sciences
Margaret Hamburg, Foreign Secretary, National Academy of Medicine Jo Handelsman, Office of Science and Technology Policy Carrie Wolinetz, National Institutes of Health |
|
| 9:15 |
Overview of the Draft NSABB Policy Framework and Key Policy Questions
Moderator: Harvey Fineberg, Symposium Planning Committee Chair |
|
Overview of the NSABB Working Paper
Samuel Stanley, Stony Brook University and NSABB Chair Harvey Fineberg, Symposium Planning Committee Chair |
|
| Open Discussion | |
| 10:45 | Break |
| 11:15 |
Informing the Policy Framework: The Risk/Benefit Assessment
Moderator: Charles Haas, Symposium Planning Committee Member |
|
Lessons from the Risk/Benefit Assessment
Rocco Casagrande, Gryphon Scientific |
|
|
Comments
Louis (Tony) Cox, Cox Associates Adam Finkel, University of Pennsylvania Kara Morgan, Battelle |
|
| Open Discussion | |
| 12:45 pm |
Lunch
(seating available in the West Court and Members Room - follow signs) |
| 1:45 |
The Policy Landscape: United States
Moderator: Michelle Mello, Symposium Planning Committee Member |
|
Discussants
Gerald Epstein, Department of Homeland Security Richard Frothingham, Duke University Lawrence Kerr, Department of Health and Human Services Philip Potter, St. Jude Children’s Research Hospital |
|
| Open Discussion | |
| 3:15 | Break |
| 3:45 |
The Policy Landscape: International Dimensions of GOF Research
Moderator: Barry Bloom, Symposium Planning Committee Member |
|
Discussants
Ruxandra Draghia-Akli, European Commission Keiji Fukuda, World Health Organization |
|
Volker ter Meulen, European Academies Science Advisory Council Silja Vöneky, University of Freiburg and German Ethics Council |
|
| Open Discussion | |
| 5:15 |
Adjourn
Reception follows in the Great Hall - all participants welcome |
| Friday, March 11: Digging Deeper: Key Issues for U.S. Policy Choices | |
| 8:30 am | Registration (coffee and tea will be served) |
| 9:00 |
Informing Policy Design: Insights from the Science of Safety and the Science of Public Consultation Moderator: Baruch Fischhoff, Symposium Planning Committee Member |
|
Discussants
Ruthanne Huising, McGill University Gavin Huntley-Fenner, Huntley-Fenner Advisors Monica Schoch-Spana, UPMC Center for Health Security |
|
| Open Discussion | |
| 10:30 | Break |
| 11:00 |
Best Practices to Inform National Policy Design and Implementation: Perspectives of Key Stakeholders in the Biomedical and Public Health Communities Moderator: Philip Dormitzer, Symposium Planning Committee Member |
|
Discussants
Michael Callahan, Massachusetts General Hospital and Harvard Medical School Robert Fisher, U.S. Food and Drug Administration Jonathan Moreno, University of Pennsylvania Ethan Settembre, Seqirus |
|
| Open Discussion | |
| 12:30 pm |
Lunch
(seating available in the West Court and Members Room - follow signs) |
| 1:30 |
International Governance: Opportunities for Harmonizing GOF Research Policy and Practice Moderator: Ronald Atlas, Symposium Planning Committee Member |
|
Discussants
Nisreen AL-Hmoud, Royal Scientific Society of Jordan George F. Gao, Chinese Academy of Sciences and China CDC Gabriel Leung, University of Hong Kong Michael Selgelid, Monash University Herawati Sudoyo, Indonesian Academy of Sciences and Eijkman Institute for Molecular Biology1 |
|
| Open Discussion | |
| 3:00 | Break |
| 3:30 |
Summing Up
Moderator: Harvey Fineberg, Symposium Planning Committee Chair |
|
Summary Remarks
Brief remarks from the moderators of the plenary sessions to summarize what emerged from the discussions during the symposium to inform the NSABB’s recommendations and the U.S. government’s policy choices. |
|
| Open Discussion | |
|
Concluding Remarks
Harvey Fineberg, Symposium Planning Committee Chair |
|
| 5:00 | Adjourn |
_______________
1 Dr. Sudoyo was unable to take part in the symposium.
